The global biosensors market size is expected to be worth around USD 63 billion by 2032 from USD 27.2 billion in 2022, growing at a CAGR of 9% during the forecast period from 2022 to 2032.
In 2025, the Biosensors Market is receiving attention from implantable and point-of-care diagnostic tools designed for chronic disease management. Miniaturized glucose, lactate, and cortisol sensors are implanted subdermally with rechargeable wireless interfaces. These devices transmit real-time biomarker readings to clinicians for ongoing remote care. Meanwhile, handheld point-of-care biosensors deliver rapid assays for troponin, CRP, and other markers in minutes—reducing time-to-treatment in emergency settings.
Clinical accuracy, portability, and seamless data platforms are positioning these sensors as essential tools in chronic care and acute diagnostics—driving better outcomes through continuous monitoring and quick decisions.
Click here for more information:
https://market.us/report/biosensors-market/Key Market Segments
Based on Technology
Thermal
Electrochemical
Piezoelectric
Optical
Other Technologies
Based on Product
Wearable
Non-Wearable
Based on Applications
Medical diagnostics
Food Toxicity Detection
Industrial Process Control
Environmental Analysis
Agricultural Testing
Other Applications
Based on End Users
Home Healthcare Diagnostics
POC Testing
Food Industry
Research Laboratories
Security & Bio-Defense
Emerging Trends
Rechargeable subdermal sensors providing weekly glucose and cortisol monitoring.
Pocket biosensor devices delivering cardiac biomarker results in under 10 minutes.
Certification of implantable sensors for long-term remote patient monitoring.
Data platforms integrating implant and POC sensor outputs into clinician dashboards.
Use Cases
A diabetic wears an implanted glucose/cortisol sensor that auto-adjusts insulin dosing through pump integration.
An ER clinician uses a handheld troponin sensor to rule out heart attack rapidly in triage.
A heart-failure patient’s implanted sensor detects fluid imbalance, prompting remote medical alert.
An ambulatory clinic collects CRP data via POC biosensor to determine outpatient vs inpatient treatment.
Locked
